主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
B
BBP
Virtus LifeSci Biotech Products ETF
86.2
6
USD
-1.23%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-1.23%
每月变动
+2.41%
6个月变化
+9.58%
年变化
+53.38%
前一天收盘价
87.3
3
Open
86.2
6
最低价
86.2
6
High
86.2
6
交易量
1
市场
US ETFs
BBP
展开完整图表
完整图表
概览
所有持仓
热图
主要持股
Market Value
Shares
Weight %
DREYFUS GOVERNMENT CASH MANAGE
1.87 M
1.87 M
4.17%
IBRX
ImmunityBio Inc
1.81 M
289.58 K
4.03%
MIRM
Mirum Pharmaceuticals Inc
1.09 M
10.51 K
2.42%
MRNA
Moderna Inc
1.02 M
23.20 K
2.28%
Dynavax Technologies Corp
979.86 K
63.28 K
2.18%
F
FOLD
Amicus Therapeutics Inc
925.66 K
64.78 K
2.06%
NVAX
Novavax Inc
920.05 K
104.02 K
2.05%
D
DAWN
Day One Biopharmaceuticals Inc
912.30 K
81.75 K
2.03%
AXSM
Axsome Therapeutics Inc
849.58 K
4 611.00
1.89%
ARDX
Ardelyx Inc
846.27 K
110.05 K
1.89%
BNTX
BioNTech SE
819.80 K
7 207.00
1.83%
GILD
GILEAD SCIENCES INC
805.57 K
5 675.00
1.80%
IOVA
Iovance Biotherapeutics Inc
792.13 K
310.64 K
1.77%
HALO
HALOZYME THERAPEUTICS INC
787.66 K
10.98 K
1.76%
KRYS
Krystal Biotech Inc
779.64 K
2 792.00
1.74%
AMGN
Amgen Inc
735.04 K
2 150.00
1.64%
ONC
BeOne Medicines Ltd
728.75 K
2 141.00
1.62%
BMRN
BIOMARIN PHARMACEUTICAL INC
724.73 K
12.82 K
1.62%
KNSA
Kiniksa Pharmaceuticals Intern
721.69 K
16.43 K
1.61%
INCY
INCYTE CORP
716.70 K
7 162.00
1.60%
1
2
3
4
新闻
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)